Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | 3 | M-CSF | 324.0 | 65 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 288.0 | 49 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | M-CSF | 253.0 | 67 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 314.0 | 41 | ||||
RA1869 | 3 | M-CSF | 345.0 | 59 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 404.5 | 46 | ||||
N2759 | 3 | M-CSF | 382.0 | 34 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 365.0 | 51 | ||||
RA1931 | 3 | M-CSF | 306.5 | 50 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 286.0 | 66 | ||||
N2586 | 3 | M-CSF | 225.5 | 56 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 213.0 | 47 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 235.0 | 63 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 330.5 | 52 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 331.0 | 53 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 221.0 | 58 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 284.0 | 54 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 251.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 243.5 | 60 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 347.0 | 55 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 245.0 | 55 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 530.5 | 36 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 405.0 | 35 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 350.0 | 47 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | M-CSF | 313.0 | 45 |